SNCA and Parkinson disease: FCGR2B expressed in neurons functions as a receptor for a-syn fibrils and mediates cell-to-cell transmission of a-synuclein and the FCGR2B-SHP-1/-2 signaling pathway may be a therapeutic target for the progression of PD(29).